Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

Abroad (travel likely)Recruiting

Conditions

Hereditary Hemorrhagic Telangiectasia · Rendu Osler Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU d'Angers, Angers, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Christian LAVIGNE)
  • CHU de Bordeaux, Bordeaux, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Pierre DUFFAU)
  • Hôpital Ambroise Paré, Boulogne-Billancourt, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Study coordinator (Sandra Blivet)
  • CHU de Caen Normandie, Caen, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Laurent Chaussavoine)
  • CHU clermont-ferrand, Clermont-Ferrand, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Vincent GROBOST)
  • CHU de Dijon, Dijon, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Hélène GREIGERT)
  • CHRU de Lille, Lille, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Hélène Maillard)
  • Hospices Civiles de Lyon, Lyon, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Sophie Dupuis-Girod)
  • Assistance Publique - Hôpitaux de Marseille, Marseille, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Baptiste André)
  • CHU de Montpellier, Montpellier, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Sophie Rivière)
  • CHU de Nancy, Nancy, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Shirine MOHAMED)
  • CHU de Nantes, Nantes, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Giovanni Gautier)
  • CHU de Nice, Nice, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Johana PRADELLI)
  • AP-HP - Hôpital Ténon, Paris, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Michel DJIBRE)
  • CHU de Poitiers, Poitiers, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Xavier Le Guillou Horn)
  • CHU de Rennes, Rennes, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Mallorie KERJOUAN)
  • CHRU de Strasbourg, Strasbourg, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Murielle RONDEAU-LUTZ)
  • CHU de Toulouse, Toulouse, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Laurent Alric)
Study leads
  • Vincent GROBOST

    Principal Investigator

    University Hospital, Clermont-Ferrand